
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : OKL-1111
Therapeutic Area : Hematology
Study Phase : Preclinical
Sponsor : Broadview Ventures
Deal Size : $5.2 million
Deal Type : Financing
Alveron Secures €5M Seed Extension Financing for Intracranial Hemorrhage Therapy
Details : The financing aims to advance the development of its innovative drug, OKL-1111, for the treatment of intracranial haemorrhage.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
December 06, 2024
Lead Product(s) : OKL-1111
Therapeutic Area : Hematology
Highest Development Status : Preclinical
Sponsor : Broadview Ventures
Deal Size : $5.2 million
Deal Type : Financing
